To study these genotype–phenotype correlations, among other purposes, dystrophinopathy patient registries were formed by local, national, and international initiatives to collect information on patient clinical outcomes and DMD mutations. Here, DMD is linked to neuromuscular disease caused by qualitative or quantitative defects of dystrophin.